C-Reactive Protein Tests are blood tests that measure the levels of C-Reactive Protein. C-reactive protein is a protein that is produced by the liver and its level increase when there is inflammation in the body. C-reactive tests identify and keep track of infections and diseases that cause inflammation such as certain types of cancers, cardiovascular diseases, arthritis, etc. According to the WHO, an estimated 17.3 million people died of cardiovascular diseases in 2008 alone. C-reactive protein tests estimate the risks of a person suffering from heart attacks or strokes. The main drivers for this market are the increasing incidences of cardiovascular diseases, and the sheer volume of tests required. Lack of public awareness would be a challenge to growth of this market. Opportunities for this market include the increasing applications for the test, applications in point of care testing, large target populations and higher global health care awareness, especially in developing countries.
C-Reactive Protein Testing Market by application
C-reactive protein tests are used in detection of inflammation seen in cases of infections after surgeries, diseases of immune system (Lupus), Rhematoid arthritis, cancers, inflammatory bowel disease and Cardiovascular diseases. The incidence of cardiovascular disease such as heart attacks and strokes is high and these tests are important to predict the occurrence of such diseases.
C-Reactive Protein Testing Market by type of assays.
The immunoassays used for C-reactive protein testing are ELISA, Immunoturbidimetric assays, Chemiluminesence immunoassay(CLIA)and High-sensitivity C-reactive protein (hsCRP) assay. The high-sensitivity C-reactive protein (hsCRP) assay is used as a marker for assessment of cardiac risks and as a prognostic tool for heart diseases. American Heart Association (AHA) and Centers for Disease Control and Prevention (CDC) recommends hsCRP as a more sensitive assay to predict vascular disease, as compared to the more traditional assays for circulating C-reactive protein levels.
C-Reactive Protein Testing Market by Geography
C-Reactive Protein Testing Market is segmented into North America, Europe, Asia-Pacific and RoW. Currently, the market is dominated by North America and Europe due to high prevalence of cardiovascular disease. However, Asia Pacific is an emerging market as the lifestyle related diseases such as cardiovascular diseases are on the rise.
Roche Diagnostics, EMD Millipore, Life technologies, Randox, Quest Diagnostics, Abaxis Inc., and others are some of the companies in this market. In 2010, Abaxis received FDA approval for its C-Reactive Protein (CRP) assay to be used with the Piccolo Xpress point-of-care analyzer. With the help of this, health care professionals would be able to conduct on site analysis rapidly for a variety of conditions such as inflammatory diseases infections, etc.
High Level Analysis
Porter’s five force model analyzes the bargaining power of the buyer and supplier. Bargaining power of buyer seems to be high as there are many suppliers in this market. SWOT analysis would help in making informed business decisions to stay ahead of competitors. Key drivers and opportunities help in predicting future market trends. Competitive analysis identifies the key players in this market and the strategic decisions taken by them.
C-Reactive Protein Testing Market is segmented by application, type of assays and geography.
Market By Application
Market By Type Of Assays
Market By Geography